Pfizer

For every new billionaire created during the pandemic — one every 30 hours — nearly a million people could be pushed into extreme poverty in 2022 at nearly the same rate, reveals a new Oxfam brief today. “Profiting from Pain” is published as the World Economic Forum — the exclusive get-together of the global elite in Davos — takes place for the first time face-to-face since COVID-19, a period during which billionaires have enjoyed a huge boost to their fortunes. 

An Oxfam resolution before Moderna shareholders received 24 percent of the nominal vote or 29 percent of the independent vote factoring in the 17 percent of the vote share owned by the company's directors and senior executives. A similar resolution before Pfizer shareholders garnered 27 percent of the vote.
 

In separate virtual addresses to the shareholders of Moderna, Pfizer, and Johnson & Johnson (JNJ), Oxfam called on the pharmaceutical corporations to improve COVID-19 vaccine equity and access so that everyone, everywhere has access to these life-saving shots. 

In response to the publication of Pfizer’s financial results on COVID-19 vaccine sales for last year and projections for its COVID-19 vaccine and antiviral pill this year, Oxfam’s Robbie Silverman said: “Pfizer’s results today are clear evidence of how the company has used its monopoly to enrich its shareholders at the expense of almost half the world’s population who still have no access to lifesaving vaccines."
 

More doses of Covid-19 vaccines have been delivered to the EU, the UK and the United States in the six-week run up to Christmas than African countries have received all year, new analysis from the People’s Vaccine Alliance reveals today.

In reaction to Pfizer’s announcement of voluntary licenses of its COVID-19 oral antiviral treatment Paxlovid to the Medicines Patent Pool, People’s Vaccine Alliance spokesperson and Oxfam America’s Senior Advocacy Advisor, Robbie Silverman, said: “Pfizer’s announcement to voluntarily licence the COVID treatment Paxlovid is welcome but is far from enough." 
 
 

New figures from the Peoples Vaccine Alliance reveal that the companies behind two of the most successful COVID vaccines – Pfizer, BioNTech and Moderna – are making combined profits of $65,000 every minute. The figures based on the latest company reports are released as CEOs from pharmaceutical industry meet for the annual STAT summit —the equivalent of a ‘Big Pharma Davos’— from 16-18 November.

In response to the announcement that the World Health Organisation (WHO) has granted emergency use license for the COVID-19 vaccine, Covaxin, developed by Bharat Biotech in India, People’s Vaccine Alliance spokesperson and Oxfam Health Policy Manager, Anna Marriott, said: "Another approved vaccine to fight COVID-19 is fantastic news. We strongly encourage Bharat Biotech to show pandemic leadership and do the right thing for humanity by agreeing to share the vaccine technology and rights with the WHO's COVID Technology Access Pool, so that more manufacturers around the world can produce them.

As the UN General Assembly kicks off again this year, Oxfam’s experts and partners are available to speak to their work focused on the People’s Vaccine for COVID-19, the climate crisis - including climate finance, and a number of pressing humanitarian crises. 

The cost of vaccinating the world against COVID-19 could be at least five times cheaper if pharmaceutical companies weren’t profiteering from their monopolies on COVID-19 vaccines, campaigners from the People’s Vaccine Alliance said today.